Topics

ASCO/ASH update ESA recommendations

05:04 EDT 3 May 2019 | Generics and Biosimilars Initiative

The American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH) have updated their recommendations on the management of cancer-associated anaemia with erythropoiesis-stimulating agents (ESAs).

Original Article: ASCO/ASH update ESA recommendations

NEXT ARTICLE

More From BioPortfolio on "ASCO/ASH update ESA recommendations"

Quick Search